Deadline: 15 June 2025
Global Affairs Canada (GAC) through the Embassy of Canada in Seoul and in collaboration with the National Research Council Industrial Research Assistance Program (NRC IRAP), invites you to apply to participate in the Canadian AI in life sciences innovation R&D partnering delegation to South Korea under the Canadian International Innovation Program (CIIP).
Objectives
- The objective of this delegation is to connect innovative Canadian small-to-medium-sized enterprises (SMEs) applying AI technologies to life sciences with potential partners in South Korea for R&D collaboration and market expansion. Potential partners include:
- major pharmaceutical companies
- R&D centres
- healthcare organizations
Aims
The program aims to maximize visibility and partnership opportunities for Canadian participants within a strategically curated innovation ecosystem.
Focus Areas
- The delegation will focus on areas including:
- AI in drug discovery, including target identification, molecule generation, etc.
- clinical trial management and optimization
- predictive analytics in healthcare and personalized medicine
- data platforms enabling AI-driven R&D
- advanced applications of AI across the pharmaceutical value chain
- application of AI in biomanufacturing of advanced therapeutics
Funding Information
- The Canadian International Innovation Program (CIIP) may provide financial support to eligible Canadian SMEs participants for up to 50% of all eligible expenses that include but are not limited to:
- economy class airfare
- local transportation
- accommodation
- per diems
- conference registration fees
Eligibility Criteria
- The cohort will be made of 8 to 10 Canadian SMEs with demonstrated capabilities in AI-enabled life sciences.
- The delegation is targeting Canadian companies working on technologies/solutions in the focus areas listed.
- Canadian participants in the delegation should meet the following requirements:
- profit-oriented, small- or medium-sized enterprise (SME) incorporated in Canada
- previous experience in commercializing technology for domestic and/or international markets
- capacity and interest to co-develop technology with Korean partners
- committed to expanding activities to the Korean market
- sufficient working capital and human resources to undertake multi-year R&D collaboration and commercialize the results
For more information, visit Government of Canada.
